Skin Disorders News

BOSTON — Physicians suspect the solvent used in the administration of pembrolizumab may have triggered recurrent angioedema for a patient with squamous cell carcinoma, according to a poster presented at the CHEST Annual Meeting.

BOSTON — Patients with hereditary angioedema who used deucrictibant for 12 weeks experienced improved symptom control, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Dermavant Sciences presented full results from its long-term extension trial of Vtama cream 1% for the treatment of atopic dermatitis at the Fall Clinical Dermatology Conference, the company announced in a press release.

LEO Pharma presented full results from its long-term trial of Adbry for atopic dermatitis at the Fall Clinical Dermatology Conference, according to a company press release.

BOSTON — Patients with chronic spontaneous urticaria experienced significant improvements through 24 weeks with dupilumab, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Chronic spontaneous urticaria symptoms improved with 1 week of remibrutinib treatment, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Patients with hereditary angioedema saw significant reductions in attacks for 18 months after beginning berotralstat, according to two posters at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — About one-third of children with atopic dermatitis saw mild improvements with elimination diets, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Children with atopic disease had increased risks for developing eosinophilic esophagitis, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

October is National Eczema Awareness Month. It serves to bring attention to the approximately 16.5 million adults and 8 million children in the U.S. that currently suffer from the chronic skin condition.